A Study on the Expression of Site-Directed Mutated Human Proinsulin Gene in Non-Β Cell Lines

沈坤堂,秦新裕,肖华胜,张新,许相儒,韩泽广
DOI: https://doi.org/10.3760/j.issn:1001-9030.2002.03.031
2002-01-01
Abstract:Objective To study an insulin and islets transplantation replacement therapy for type Ⅰdiabetes based on engineered human non βcells,which secreted mature insulin.Methods Human proinsulin cDNA was cloned from its genomic gene and mutated by gene SOEing method,introducing furin consensus cleavage sequences (Arg Xaa Lys/Arg Arg).An expression vector encoding a genetically modified human proinsulin cDNA was generated,and transduced to Hela,293 and L02 cells by lipofectin mediated DNA transfection.48 and 72?h after the transfection,the culture media were collected for further assay.After screening with G418 (450?mg/L) for two months,the survived L02 cells secreting insulin stably were selected and enriched.Insulin levels in the supernatants and cells were evaluated respectively with radioimmunoassay and immunohistochemical analysis.Results Three sites were mutated simultaneously.Insulin gene modified cells were able to express insulin at different levels,8.45 to 188.00 μIU/(2.0×10 6 Hela cells·d -1 ),159.88 to 242.14?μIU/(2.0×10 6 293 cells·d -1 ),and 2.56 to 61.95?μIU/(2.0×10 6 L02 cells·d -1 ),while no insulin was released by control cells.Immunohistochemical analysis confirmed that (pro)insulin was stored as vacuoles in the cytoplasm of L02 cells.Conclusion A correctly mutated human proinsulin cDNA was obtained successfully,transfected,and expressed efficiently in non βcells.
What problem does this paper attempt to address?